Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections

Infection

Volumn 45, Issue 3, 2017, Pages 255-262

  Chen, Shuyi ^a   Gu, Huawei ^a   Sun, Chunli ^a   Wang, Haiying ^a   Wang, Jufang ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Clostridium difficile infection (CDI); Rapid testing; TcdA; TcdB

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; GLUTAMATE DEHYDROGENASE; BACTERIAL TOXIN;

ALGORITHM; BACTERIUM CULTURE; BACTERIUM DETECTION; CLOSTRIDIUM DIFFICILE INFECTION; CYTOTOXICITY ASSAY; CYTOTOXIGENIC CULTURE; ENZYME IMMUNOASSAY; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MULTICENTER STUDY (TOPIC); NUCLEIC ACID AMPLIFICATION; PEPTOCLOSTRIDIUM DIFFICILE; RAPID TEST; REVIEW; CLOSTRIDIUM INFECTION; ISOLATION AND PURIFICATION; LABORATORY TECHNIQUE; MICROBIOLOGY; PSEUDOMEMBRANOUS COLITIS; STANDARDS;

BACTERIAL TOXINS; CLINICAL LABORATORY TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS;

EID: 84986271699     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-016-0940-9     Document Type: Review

References (70)

1. Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology. 1978;75:778–82.
2. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320:204–10. doi:10.1056/NEJM198901263200402.
3. Steele SR, McCormick J, Melton GB, Paquette I, Rivadeneira DE, Stewart D, et al. Practice parameters for the management of Clostridium difficile infection. Dis Colon Rectum. 2015;58:10–24. doi:10.1097/DCR.0000000000000289.
4. Kelly CP, LaMont JT. Clostridium difficile infection. Annu Rev Med. 1998;49:375–90. doi:10.1146/annurev.med.49.1.375.
5. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev. 2005;18:247–63. doi:10.1128/CMR.18.2.247-263.2005.
6. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55. doi:10.1086/651706.
7. Kelly CP, LaMont JT. Clostridium difficile—more difficult than ever. N Engl J Med. 2008;359:1932–40. doi:10.1056/NEJMra0707500.
8. Carter GP, Rood JI, Lyras D. The role of toxin A and toxin B in the virulence of Clostridium difficile. Trends Microbiol. 2012;20:21–9. doi:10.1016/j.tim.2011.11.003.
9. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366:1079–84. doi:10.1016/S0140-6736(05)67420-X.
10. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442–9. doi:10.1056/NEJMoa051639.
11. Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171:466–72. doi:10.1503/cmaj.1041104.
12. Popoff MR, Boquet P. Clostridium spiroforme toxin is a binary toxin which ADP-ribosylates cellular actin. Biochem Biophys Res Commun. 1988;152:1361–8. doi:10.1016/S0006-291X(88)80435-2.
13. Popoff MR, Rubin EJ, Gill DM, Boquet P. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun. 1988;56:2299–306.
14. Eckert C, Emirian A, Le Monnier A, Cathala L, De Montclos H, Goret J, et al. Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B. New Microbes New Inect. 2014;3:12–7. doi:10.1016/j.nmni.2014.10.0003.
15. Gerding DN, Johnson S, Rupnik M, Aktories K. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes. 2014;5:15–27. doi:10.4161/gmic.26854.
16. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46:S12–8. doi:10.1086/521863.
17. Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313:398–408. doi:10.1001/jama.2014.17103.
18. Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec. Canada Clin Infect Dis. 2005;40:1591–7. doi:10.1086/430315.
19. Vardakas KZ, Polyzos KA, Patouni K, Rafailidis PI, Samonis G, Falagas ME. Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents. 2012;40:1–8. doi:10.1016/j.ijantimicag.2012.01.004.
20. Chen S, Sun C, Wang H, Wang J. The role of rho GTPases in toxicity of Clostridium difficile toxins. Toxins (Basel). 2015;7:5254–67. doi:10.3390/toxins7124874.
21. Steiner C, Barrett M, Sun Y, Weiss A. HCUP projections: Clostridium difficile hospitalizations 2003–2014. HCUP projections report #2014-03. (U.S Agency for Healthcare Research and Quality.). 2014. http://www.hcup-us.ahrq.gov/reports/projections/2014-03.pdf. Accessed 19 Nov 2014.
22. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825–34. doi:10.1056/NEJMoa1408913.
23. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg. 2007;142:624–31. doi:10.1001/archsurg.142.7.624 (discussion 31).
24. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009;7:526–36. doi:10.1038/nrmicro2164.
25. Shields K, Araujo-Castillo RV, Theethira TG, Alonso CD, Kelly CP. Recurrent Clostridium difficile infection: from colonization to cure. Anaerobe. 2015;34:59–73. doi:10.1016/j.anaerobe.2015.04.012.
26. McFarland LV. Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients. Am J Infect Control. 1995;23:295–305.
27. Garey KW, Graham G, Gerard L, Dao T, Jiang ZD, Price M, et al. Prevalence of diarrhea at a university hospital and association with modifiable risk factors. Ann Pharmacother. 2006;40:1030–4. doi:10.1345/aph.1H028.
28. Planche T, Wilcox MH. Diagnostic pitfalls in Clostridium difficile infection. Infect Dis Clin North Am. 2015;29:63–82. doi:10.1016/j.idc.2014.11.008.
29. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 2002;346:334–9. doi:10.1056/NEJMcp011603.
30. Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ. 2004;171:51–8.
31. Freeman J, Baines SD, Jabes D, Wilcox MH. Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection. J Antimicrob Chemother. 2005;56:717–25. doi:10.1093/jac/dki321.
32. Riley TV, Brazier JS, Hassan H, Williams K, Phillips KD. Comparison of alcohol shock enrichment and selective enrichment for the isolation of Clostridium difficile. Epidemiol Infect. 1987;99:355–9.
33. Marler LM, Siders JA, Wolters LC, Pettigrew Y, Skitt BL, Allen SD. Comparison of five cultural procedures for isolation of Clostridium difficile from stools. J Clin Microbiol. 1992;30:514–6.
34. Hink T, Burnham CA, Dubberke ER. A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens. Anaerobe. 2013;19:39–43. doi:10.1016/j.anaerobe.2012.12.001.
35. George WL, Sutter VL, Citron D, Finegold SM. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol. 1979;9:214–9.
36. Wren M. Clostridium difficile isolation and culture techniques. Mehtods Mol Biol. 2010;646:39–52. doi:10.107/978-1-60327-365-7_3.
37. Burnham CA, Carroll KC. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev. 2013;26:604–30. doi:10.1128/CMR.00016-13.
38. Wilcox MH, Planche T, Fang FC, Gilligan P. What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J Clin Microbiol. 2010;48:4347–53. doi:10.1128/JCM.02028-10.
39. Planche T, Wilcox M. Reference assays for Clostridium difficile infection: one or two gold standards? J Clin Pathol. 2011;64:1–5. doi:10.1136/jcp.2010.080135.
40. Lashner BA, Todorczuk J, Sahm DF, Hanauer SB. Clostridium difficile culture-positive toxin-negative diarrhea. Am J Gastroenterol. 1986;81:940–3.
41. Barbut F, Braun M, Burghoffer B, Lalande V, Eckert C. Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J Clin Microbiol. 2009;47:1276–7. doi:10.1128/JCM.00309-09.
42. Eastwood K, Else P, Charlett A, Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol. 2009;47:3211–7. doi:10.1128/JCM.01082-09.
43. Peterson LR, Manson RU, Paule SM, Hacek DM, Robicsek A, Thomson RB Jr, et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis. 2007;45:1152–60. doi:10.1086/522185.
44. Stamper PD, Alcabasa R, Aird D, Babiker W, Wehrlin J, Ikpeama I, et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol. 2009;47:373–8. doi:10.1128/JCM.01613-08.
45. de Jong E, de Jong AS, Bartels CJ, van der Rijt-van den Biggelaar C, Melchers WJ, Sturm PD. Clinical and laboratory evaluation of a real-time PCR for Clostridium difficile toxin A and B genes. Eur J Clin Microbiol Infect Dis. 2012;31:2219–25. doi:10.1007/s10096-012-1558-1.
46. Landry ML, Ferguson D, Topal J. Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease. J Clin Microbiol. 2014;52:275–80. doi:10.1128/JCM.02545-13.
47. Murray PR, Weber CJ. Detection of Clostridium difficile cytotoxin in HEp-2 and CHO cell lines. Diagn Microbiol Infect Dis. 1983;1:331–3.
48. Doern GV, Coughlin RT, Wu L. Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays. J Clin Microbiol. 1992;30:2042–6.
49. George WL, Rolfe RD, Finegold SM. Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. J Clin Microbiol. 1982;15:1049–53.
50. George WL, Rolfe RD, Harding GK, Klein R, Putnam CW, Finegold SM. Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis. Infection. 1982;10:205–8.
51. Gerding DN, Olson MM, Peterson LR, Teasley DG, Gebhard RL, Schwartz ML, et al. Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med. 1986;146:95–100.
52. Planche TD, Davies KA, Coen PG, Finney JM, Monahan IM, Morris KA, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis. 2013;13:936–45. doi:10.1016/S1473-3099(13)70200-7.
53. van den Berg RJ. Bruijnesteijn van Coppenraet LS, Gerritsen HJ, Endtz HP, van der Vorm ER, Kuijper EJ. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients. J Clin Microbiol. 2005;43:5338–40. doi:10.1128/JCM.43.10.5338-5340.2005.
54. Le Guern R, Herwegh S, Grandbastien B, Courcol R, Wallet F. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples. J Clin Microbiol. 2012;50:3089–90. doi:10.1128/JCM.01250-12.
55. Novak-Weekley SM, Marlowe EM, Miller JM, Cumpio J, Nomura JH, Vance PH, et al. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol. 2010;48:889–93. doi:10.1128/JCM.01801-09.
56. Sloan LM, Duresko BJ, Gustafson DR, Rosenblatt JE. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol. 2008;46:1996–2001. doi:10.1128/JCM.00032-08.
57. Han Z, McMullen KM, Russo AJ, Copper SM, Warren DK, Dubberke ER. A Clostridium difficile infection “intervention”: change in toxin assay results in fewer C difficile infection cases without changes in patient outcomes. Am J Infect Control. 2012;40:349–53. doi:10.1016/j.ajic.2011.04.002.
58. Planche T, Aghaizu A, Holliman R, Riley P, Poloniecki J, Breathnach A, et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis. 2008;8:777–84. doi:10.1016/S1473-3099(08)70233-0.
59. Fang YS, Chen SY, Huang XJ, Wang LS, Wang HY, Wang JF. Simple approach for ultrasensitive electrochemical immunoassay of Clostridium difficile toxin B detection. Biosens Bioelectron. 2014;53:238–44. doi:10.1016/j.bios.2013.09.063.
60. Song L, Zhao M, Duffy DC, Hansen J, Shields K, Wungjiranirun M, et al. Development and validation of digital enzyme-linked immunosorbent assays for ultrasensitive detection and quantification of Clostridium difficile toxins in stool. J Clin Microbiol. 2015;53:3204–12. doi:10.1128/JCM.01334-15.
61. Wren B, Clayton C, Tabaqchali S. Rapid identification of toxigenic Clostridium difficile by polymerase chain reaction. Lancet. 1990;335:423.
62. Kato N, Ou CY, Kato H, Bartley SL, Brown VK, Dowell VR Jr, et al. Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J Clin Microbiol. 1991;29:33–7.
63. Gumerlock PH, Tang YJ, Meyers FJ, Silva J Jr. Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces. Rev Infect Dis. 1991;13:1053–60.
64. Gumerlock PH, Tang YJ, Weiss JB, Silva J Jr. Specific detection of toxigenic strains of Clostridium difficile in stool specimens. J Clin Microbiol. 1993;31:507–11.
65. Longtin Y, Trottier S, Brochu G, Paquet-Bolduc B, Garenc C, Loungnarath V, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013;56:67–73. doi:10.1093/cid/cis840.
66. Ticehurst JR, Aird DZ, Dam LM, Borek AP, Hargrove JT, Carroll KC. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol. 2006;44:1145–9. doi:10.1128/JCM.44.3.1145-1149.2006.
67. Fenner L, Widmer AF, Goy G, Rudin S, Frei R. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol. 2008;46:328–30. doi:10.1128/JCM.01503-07.
68. Reller ME, Lema CA, Perl TM, Cai M, Ross TL, Speck KA, et al. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol. 2007;45:3601–5. doi:10.1128/JCM.01305-07.
69. Wren MW, Sivapalan M, Kinson R, Shetty NR. Laboratory diagnosis of Clostridium difficile infection. An evaluation of tests for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenic culture in the diagnostic laboratory. Br J Biomed Sci. 2009;66:1–5.
70. Sharp SE, Ruden LO, Pohl JC, Hatcher PA, Jayne LM, Ivie WM. Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J Clin Microbiol. 2010;48:2082–6. doi:10.1128/JCM.00129-10.